DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ: 067080)

DAE HWA Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Cash & Equivalents	2,453	2,698	6,250	8,246	11,816	2,863
Short-Term Investments	5,360	7,320	9,899	6,273	3,010	2,230
Trading Asset Securities	2,019	1,876	-	-	-	-
Cash & Short-Term Investments	9,832	11,894	16,149	14,518	14,826	5,093
Cash Growth	-69.69%	-26.35%	11.23%	-2.08%	191.12%	-36.19%
Accounts Receivable	15,485	16,759	16,405	23,723	26,221	26,259
Other Receivables	2,255	3,148	2,095	1,973	1,454	1,316
Receivables	17,739	19,907	18,500	25,696	27,675	27,575
Inventory	18,882	17,162	14,559	13,511	18,576	20,927
Prepaid Expenses	579.61	329.69	783.81	372.38	41.45	42.79
Other Current Assets	772.25	485.35	926.19	1,096	859.97	2,249
Total Current Assets	47,805	49,777	50,918	55,195	61,978	55,888
Property, Plant & Equipment	69,717	68,913	64,473	66,044	70,179	49,623
Long-Term Investments	11,564	11,221	13,707	15,999	7,545	6,800
Goodwill	3,091	3,091	4,013	4,013	2,353	2,353
Other Intangible Assets	14,646	14,322	13,326	10,076	5,680	5,355
Long-Term Deferred Tax Assets	2,706	2,706	4,277	2,581	2,474	918.55
Other Long-Term Assets	16,076	16,115	11,342	11,557	3,556	3,624
Total Assets	165,605	166,145	162,055	165,475	153,803	124,609
Accounts Payable	8,935	8,830	6,849	10,210	10,602	11,272
Accrued Expenses	2,554	4,048	3,107	2,926	2,664	2,446
Short-Term Debt	45,327	44,734	44,638	49,176	47,358	29,722
Current Portion of Leases	570.84	316.77	-	-	-	-
Current Income Taxes Payable	2,493	3,251	2,428	2,406	1,547	1,724
Current Unearned Revenue	77.11	80.75	492.56	407.67	227.24	200.35
Other Current Liabilities	10,594	9,419	4,466	3,190	3,138	2,627
Total Current Liabilities	70,551	70,680	61,981	68,315	65,536	47,990
Long-Term Debt	6,000	6,000	321.67	68.42	2,222	3,889
Long-Term Leases	149.86	483.9	-	-	-	-
Long-Term Deferred Tax Liabilities	21.18	-	528.97	-	-	-
Other Long-Term Liabilities	3,527	3,477	4,345	3,728	2,460	2,542
Total Liabilities	82,324	82,095	78,856	81,987	80,412	62,877
Common Stock	9,112	9,112	9,112	9,112	9,112	9,112
Additional Paid-In Capital	24,576	24,576	24,576	24,576	24,214	24,214
Retained Earnings	50,848	51,646	44,905	42,253	30,703	29,439
Treasury Stock	-9,162	-8,996	-2,032	-2,032	-2,134	-2,134
Comprensive Income & Other	3,246	3,009	318.56	2,845	4,255	423.92
Total Common Equity	78,621	79,347	76,881	76,755	66,151	61,055
Minority Interest	4,660	4,703	6,319	6,733	7,240	677.14
Shareholders' Equity	83,281	84,051	83,199	83,488	73,391	61,732
Total Liabilities & Equity	165,605	166,145	162,055	165,475	153,803	124,609
Total Debt	52,048	51,535	44,960	49,245	49,580	33,610
Net Cash (Debt)	-42,216	-39,641	-28,811	-34,726	-34,754	-28,517
Net Cash Per Share	-2326.51	-2167.53	-1629.17	-1964.85	-1966.28	-1611.44
Filing Date Shares Outstanding	17.12	17.14	17.68	17.68	17.66	17.66
Total Common Shares Outstanding	17.12	17.14	17.68	17.68	17.66	17.66
Working Capital	-22,746	-20,903	-11,063	-13,120	-3,558	7,898
Book Value Per Share	4591.03	4629.96	4347.40	4340.27	3746.41	3457.82
Tangible Book Value	60,885	61,934	59,543	62,667	58,118	53,348
Tangible Book Value Per Share	3555.31	3613.90	3366.98	3543.62	3291.50	3021.32
Land	-	19,054	22,749	23,755	29,736	8,549
Buildings	-	44,462	37,815	38,845	35,156	33,898
Machinery	-	36,042	34,286	34,247	30,160	28,331
Construction In Progress	-	5,573	2,746	133.8	417.2	387.3

Source: S&P Capital IQ. Standard template. Financial Sources.